The biopharma industry is undergoing a digital transformation, with innovation and technology expected to play a key role in its future. Digitalization is seen as essential for areas such as supply chains, manufacturing, and clinical trials, with some outlets suggesting that artificial intelligence and a digital backbone will be particularly important. The extent to which medtech has already entered this era of digital innovation is unclear, with some outlets exploring the challenges and decisions involved in this transformation.